Alterations in GABAA Receptor Subunit Expression in the Amygdala and Entorhinal Cortex in Human Temporal Lobe Epilepsy

• Published in: Journal of neuropathology and experimental neurology 2019-11, Vol.78 (11), p.1022-1048
• Main Authors: Stefanits, Harald, Milenkovic, Ivan, Mahr, Nina, Pataraia, Ekaterina, Baumgartner, Christoph, Hainfellner, Johannes A, Kovacs, Gabor G, Kasprian, Gregor, Sieghart, Werner, Yilmazer-Hanke, Deniz, Czech, Thomas
• Format: Article
• Language: English
• ISSN: 0022-3069; 1554-6578
• DOI: 10.1093/jnen/nlz085

Abstract The amygdala has long been implicated in the pathophysiology of human temporal lobe epilepsy (TLE). The different nuclei of this complex structure are interconnected and share reciprocal connections with the hippocampus and other brain structures, partly via the entorhinal cortex. Expression of GABAA receptor subunits α1, α2, α3, α5, β2, β2/3, and γ2 was evaluated by immunohistochemistry in amygdala specimens and the entorhinal cortex of 12 TLE patients and 12 autopsy controls. A substantial decrease in the expression of α1, α2, α3, and β2/3 subunits was found in TLE cases, accompanied by an increase of γ2 subunit expression in many nuclei. In the entorhinal cortex, the expression of all GABAA receptor subunits was decreased except for the α1 subunit, which was increased on cellular somata. The overall reduction in α subunit expression may lead to decreased sensitivity to GABA and its ligands and compromise phasic inhibition, whereas upregulation of the γ2 subunit might influence clustering and kinetics of receptors and impair tonic inhibition. The description of these alterations in the human amygdala is important for the understanding of network changes in TLE as well as the development of subunit-specific therapeutic agents for the treatment of this disease.